ANCA Vasculitis: Stopping Immunosuppressive Therapy

We are studying whether stopping immunosuppressive therapy helps patients with ANCA vasculitis and end-stage renal disease avoid serious health issues compared to continuing treatment.

>2 years 11-15 visits Confirmation phase (III)Monitoring phase (IV)No Placebo Standard Medicines Oral InjectionNephrologyRheumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Cortancyl

Cortancyl is a steroid medicine used to reduce inflammation and treat allergies, asthma, and certain autoimmune or inflammatory conditions.

Imurel

Imurel is a medicine that suppresses the immune system to prevent organ transplant rejection and treat autoimmune diseases like rheumatoid arthritis and Crohn’s.

Mycophenolate Mofetil Tillomed

Mycophenolate Mofetil Tillomed is a medicine that suppresses the immune system to prevent organ transplant rejection and treat some autoimmune conditions.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Azathioprine

Azathioprine is a substance that suppresses the immune system to prevent organ rejection and treat autoimmune diseases.

Mycophenolate Mofetil

Mycophenolate mofetil is a substance that suppresses the immune system to prevent organ transplant rejection and treat autoimmune conditions.

Mycophenolic Acid

Mycophenolic acid is a substance that suppresses the immune system to help prevent organ transplant rejection and control autoimmune diseases.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Atsimutin

Azafalk

Azafor

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Centre Hospitalier Universitaire Amiens Picardie

Nephrology

Amiens, France

Centre Hospitalier Universitaire D'Angers

Nephrology

Angers, France

Centre Hospitalier De Valenciennes

Nephrology

Anzin, France

Sponsor: Centre Hospitalier Departemental Vendee

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.